Sino Medical Sciences Technology Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Jianhua Sun
Chief executive officer
CN¥1.1m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 20.0% |
| Management average tenure | no data |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
Is Sino Medical Sciences Technology (SHSE:688108) Using Debt Sensibly?
Nov 19
Revenues Tell The Story For Sino Medical Sciences Technology Inc. (SHSE:688108) As Its Stock Soars 25%
Sep 24What Sino Medical Sciences Technology Inc.'s (SHSE:688108) P/S Is Not Telling You
Jun 03Optimistic Investors Push Sino Medical Sciences Technology Inc. (SHSE:688108) Shares Up 26% But Growth Is Lacking
Mar 05Is Sino Medical Sciences Technology (SHSE:688108) Using Debt In A Risky Way?
Feb 28CEO
Jianhua Sun (63 yo)
no data
Tenure
CN¥1,117,470
Compensation
Mr. Jianhua Sun serves as Chairman and General Manager of Sino Medical Sciences Technology Inc.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥1.12m | 19.95% CN¥ 791.1m | |
| CFO & Director | no data | CN¥1.22m | 0.041% CN¥ 1.6m | |
| Deputy GM & Director | no data | CN¥1.18m | 0.16% CN¥ 6.4m | |
| Board Secretary & Director | no data | CN¥572.53k | 0.0070% CN¥ 276.4k | |
| Director | 2.7yrs | CN¥1.13m | 0.041% CN¥ 1.6m | |
| Chairman of the Board of Supervisors | no data | no data | no data | |
| Employee Representative Supervisor | 2.8yrs | no data | 0.00058% CN¥ 23.0k | |
| Employee Representative Supervisor | 2.8yrs | no data | 0.033% CN¥ 1.3m | |
| Director | 3.6yrs | CN¥987.44k | 0.041% CN¥ 1.6m | |
| Independent Director | 6.6yrs | CN¥80.00k | no data | |
| Independent Director | 4.1yrs | CN¥80.00k | no data | |
| Independent Director | 4.6yrs | CN¥80.00k | no data |
3.6yrs
Average Tenure
48.5yo
Average Age
Experienced Board: 688108's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 03:09 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sino Medical Sciences Technology Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuo Song | Citic Securities Co., Ltd. |
| Zhuo Huang | Everbright Securities Co. Ltd. |